PFM Health Sciences’s Atlassian TEAM Stock Holding History

PFM Health Sciences’s Portfolio TEAM Stock Details TEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-98,357	Closed	-$2.96M	–	93
2015 Q4	$2.96M	Buy	+98,357	New	+$2.8M	0.09%	63

Other funds holding TEAM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

PFM Health Sciences's TEAM Position: Q1 2016 in Review

PFM Health Sciences sold out of Atlassian (TEAM) in Q1 2016, closing a stake of 98,357 shares — an estimated $2.96M sold.

PFM Health Sciences first reported a position in TEAM in Q4 2015 and held it in 1 quarter. The position peaked at $2.96M in Q4 2015. 97 funds tracked by Wall St. Rank hold TEAM as of Q1 2016.

PFM Health Sciences reported no remaining Atlassian position as of Q1 2016 after selling out during the quarter.
PFM Health Sciences sold 98,357 Atlassian shares in Q1 2016, an estimated $2.96M.
PFM Health Sciences first reported a position in Atlassian in Q4 2015 and held it in 1 quarter.
PFM Health Sciences's Atlassian position peaked at $2.96M in Q4 2015.
97 funds tracked by Wall St. Rank held Atlassian as of Q1 2016.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.